HIV (Human Immunodeficiency Virus) is a virus that attacks the body’s immune system, specifically the CD4 cells (T cells), which help the immune system fight off infections. If left untreated, HIV can lead to the disease AIDS (Acquired Immunodeficiency Syndrome). Unlike some other viruses, the human body cannot get rid of HIV completely, so once someone has HIV, they have it for life. Modern medical treatments such as antiretroviral therapy can control the virus and help prevent transmission so that people with HIV, and those at substantial risk, can enjoy healthy, long and productive lives.
Results from NIH-funded animal models will inform the development of vaccines for humans. Using advanced immunological techniques, researchers have effectively activated the immune systems of…
Researchers at Sanford Burnham Prebys have discovered positive connections between certain HIV medications and Alzheimer’s disease. Nearly seven million individuals in the U.S. are currently…
Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral medication aimed at combating human immunodeficiency…
A clinical trial demonstrated that semaglutide safely reduced liver fat by 31% in individuals with HIV and MASLD. This first study of its kind, conducted…
NIH-funded trial shows promising outcomes with treatment started promptly after birth. Four children have remained free of detectable HIV for more than one year after…
The virus’s capsid functions as a molecular transporter. Every year, approximately one million people globally contract HIV, the virus responsible for AIDS. For the virus…
Chemists from the University of Chicago have successfully assembled a massive model of the nuclear pore complex and the HIV-1 virus capsid. Because viruses have…
Researchers have found that three different HIV antibodies targeting the fusion peptide can protect monkeys from simian-HIV, offering promising insights for the development of an…
Researchers have identified “Post-treatment controllers” in HIV-1 carriers who can manage the virus after stopping treatment. A specific antibody, EPTC112, plays a crucial role in…
Novel vaccine includes NIH-funded technology in development since 2004. A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and…
An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to…
HIV drug helps protect against build-up of dementia-related proteins in mouse brains. Cambridge scientists have shown how the brain’s ability to clear out toxic proteins…
New research unveils initial insights into the mechanisms by which stem cell transplantation can eliminate the virus responsible for AIDS. New findings from Oregon Health…
MitoQ, a publicly accessible dietary supplement that acts as a mitochondrial antioxidant, was discovered through a mouse study to counteract the harmful impacts that HIV…
An international study coordinated by the MELIS-UPF researchers Andreas Meyerhans and Juana Díez has identified Schlafen 12, a new HIV restriction factor that could pave…
Researchers from Temple University and UNMC collaborate in a study recently published in the journal Proceedings of the National Academy of Sciences. Gene-editing therapy targeting…
Scientists report lasting success in a novel method to cure HIV that involves transplanting HIV-resistant stem cells from umbilical cord blood. The technique was effectively…
The NIH stopped a clinical trial early after finding that daily statin medication, pitavastatin calcium, reduced cardiovascular disease risk in people living with HIV by…